Antipyrone Inj. ® Solution for injection Suudi Arabistan - İngilizce - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

antipyrone inj. ® solution for injection

the arab pesticides & veterinary drugs manufacturing (mobedco), jordan - dipyrone (metamizole) - solution for injection - 500 mg/ml

Metalgen Solution for injection Suudi Arabistan - İngilizce - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

metalgen solution for injection

saudi pharmaceutical industries (spi), saudi arabia - dipyrone (metamizole) - solution for injection - 500 mg/ml

Metalgen Solution for injection Suudi Arabistan - İngilizce - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

metalgen solution for injection

saudi pharmaceutical industries (spi), saudi arabia - dipyrone (metamizole) - solution for injection - 500 mg/ml

Spasmovet 500mg/4mg per Ml Solution For Injection (IM/IV/SC) Filipinler - İngilizce - FDA (Food And Drug Administration)

spasmovet 500mg/4mg per ml solution for injection (im/iv/sc)

dipyrone , hyoscine butyl bromide (vet.) - solution for injection (im/iv/sc) - 500mg/4mg per ml

OPTALGIN INJECTION İsrail - İngilizce - Ministry of Health

optalgin injection

teva pharmaceutical indust.ltd - dipyrone 1 g / 2 ml - solution for injection - metamizole sodium - as an analgesic: optalgin injection, by intravenous administration, is indicated for the relief of severe and acute pain when oral treatment is not feasible or suitable, as in post-traumatic or post-surgical pain, biliary or renal colic, and pain associated with malignant diseases. intravenous administration of dipyrone should be carried out slowly over a period of at least 5 minutes, followed by reasonable clinical observation. intramuscular administration of dipyrone for relief of pain is not recommended.however, if medical circumstances require such administration, all due precautions should be exercised to permit reasonable clinical observation. as an antipyretic: optalgin injection by intramuscular administration is indicated to lower temperature in life-threatening situations, when this cannot be achieved by other means. hyperthermic patients in critical condition may also be treated in non-hospital environment, under close medical supervision.

Scopex Co Tablets Namibya - İngilizce - Namibia Medicines Regulatory Council

scopex co tablets

adcock ingram ltd - hyoscine butylbromide , dipyrone - tablet - each tablet contains hyoscine butylbromide 10 mg, dipyrone 250 mg

Buscopan Compositum 20 mg/2.5 g Ampoule Namibya - İngilizce - Namibia Medicines Regulatory Council

buscopan compositum 20 mg/2.5 g ampoule

bohringer ingelheim pharmaceuticals (pty) ltd - hyoscine-n-butylbromide, dipyrone. - injection - each 5 ml ampoule contains hyoscine-n-butylbromide 20 mg, dipyrone 2.5 mg

BUSCOPAN COMPOSITUM SPASMOLYTIC AND ANALGESIC Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

buscopan compositum spasmolytic and analgesic

boehringer ingelheim pty limited, vetmedica division - dipyrone | hyoscine-n-butylbromide - v1a + v2b * vet - dog | horse | horse foal | bitch | castrate | colt | donkey | endurance horse | filly | foal | gelding | high performance horses - not applicable (vet)